Our international network, ICFG, is delighted to announce that independent investment boutique Boltendahl International Partners has joined our group, strengthening and developing our presence in Europe and bringing a strong expertise in both the Life Sciences and Pharmaceutical fields.
Founded in 1996, Boltendahl is headquartered in Madrid and is an independent international investment firm providing M&A and Venture Capital services for both buyers and sellers, operating in several markets.
With more than 25 years in the investment banking sector, Boltendahl International Partners has a strong relationship network around the world, and is a recognised specialist player in the Pharma and Healthcare sectors.
Founder and Managing Partner Juan Capurro Boltendahl has himself over 25 years experience in investment banking, with specific sector expertise in the Life Sciences including pharmaceuticals and healthcare, biotech, medical devices, animal health and MedTech. He is an advisor of international companies and major funds across both their acquisition and divestment strategies, and during his career has advised on more than 240 M&A transactions.
Juan Capurro has joined the ICFG Healthcare Practice Group, in which HMT Partner James Thomas plays an active role. Other members of this specialised vertical include colleagues from member firms in the USA, Germany and France, combining their expertise and knowledge in the Telehealth and Biopharmaceutical space.
ICFG and Boltendahl are looking forward to the opportunities this association will bring to all parties, with more cross-border deal opportunities on the horizon.
Juan Capurro Boltendahl, Managing Partner at Boltendahl commented:
“We are excited by the way we can highlight the creativity and strengths of Iberian companies to global investors and introduce our Life Sciences opportunities to global possibilities. ICFG’s focus on assisting high quality and growth companies to identify and execute cross-border M&A and Capital Services transactions will provide a new opportunity for Spanish companies and investors to expand their international reach”.
Christophe Pothier, Chairman of ICFG commented:
“We are very proud to write a new chapter in the ICFG journey by building up our presence in the very complex and active Life Sciences space and establishing a solid footprint in the Iberian peninsula. We are very excited at the new horizons this association will bring to our clients all over the network”.